News & Topics

HOME > News & Topics > Research > 2009年度 > Immunogenicity of Whole-Parasite Vaccines against Plasmodium falciparum Involves Malarial Hemozoin and Host TLR9 (Coban 准教授がCell Host & Microbe に掲載)

Immunogenicity of Whole-Parasite Vaccines against Plasmodium falciparum Involves Malarial Hemozoin and Host TLR9 (Coban 准教授がCell Host & Microbe に掲載)

免疫学フロンティア研究センターのCoban 准教授の論文がCell Host & Microbe に掲載されました。

Article "Immunogenicity of Whole-Parasite Vaccines against Plasmodium falciparum Involves Malarial Hemozoin and Host TLR9"
Pre. Review< "Hemozoin: Malaria's Built-InAdjuvant and TLR9 Agonist" While whole-parasite vaccine strategies for malaria infection have regained attention, although their immunological mechanisms of action remain unclear. We found in this study that:

  1. Crude extract from blood stages of P. falciparum is effective as a whole blood-stage parasite vaccine via TLR9.
  2. The malarial heme-detoxification byproduct, hemozoin, but not malarial DNA, acts as a 'built-in' adjuvant.
  3. Both synthetic and natural hemozoin bind directly to TLR9 and induce conformational changes in the receptor.
  4. The adjuvant effect of synthetic hemozoin depends on its method of synthesis and particle size.
  5. Natural and synthetic hemozoin use different receptors for their adjuvant effect
  6. The adjuvant function of synthetic hemozoin was further validated in a canine anti-allergen vaccine and malaria vaccine models. Hemozoin, both in synthetic and native form, can influence adaptive immune responses to malaria infection, and may have therapeutic value in vaccine adjuvant development.

090121_coban2.JPG
090121_coban1.JPG

Archives

 
TOPに戻る